For instance, with respect to the reported cancer cases from Table 1, the titin (TTN) appeared to be mutated in the following percentages of reported cases: 12.41 of bladder cases, 2.75 of bone marrow, 14.47 of brain, 2.99 of breast, 5.05 of colorectal, 10.28 of head and neck, 5.71 of kidneys, 6.88 of lungs, 2.17 of pancreas, 2.60 of prostate, 13.46 of skin, 15.51 of stomach, and 12.21 of uterus cases. Here, TTN is linked to cancer.